Back to Search Start Over

Time To Next Anti-lymphoma Therapy (ttnt) and Treatment-free Interval (tfi) With Bortezomib-rituximab (vcr) Vs Rituximab (r) In Patients (pts) With Relapsed Follicular Lymphoma (fl)